STALLERGENES GREER |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| - EUR | -.--% |
|
+0.14% | +29.68% |
| 2023 | Nestle Reportedly May Sell Peanut Allergy Therapy to Stallergenes | CI |
| 2023 | Stallergenes Greer Ltd Initiates European Paediatric Phase III Study with Staloral Birch | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| STALLERGENES GREER | Specialty & Advanced Pharmaceuticals | -.--% | +0.14% | - | - | - | 0 | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- STAGR Stock
- Charts Stallergenes Greer
- Comparison Chart
